POLYAMINO ACID SYNTHESIS SERVICES

Brand Owner (click to sort) Address Description
ALAMANDA POLYMERS Alamanda Polymers, Inc. Suite A 1031 Putnam Drive Huntsville AL 35816 Polyamino acid synthesis services, namely, providing customized polyamino acids for laboratory and research use relating to encapsulation, gene therapy, drug delivery, cell adhesion, and surface coating; Providing consulting services and advice regarding polyamino acid synthesis for laboratory and research use relating to encapsulation, gene therapy, drug delivery, cell adhesion, and surface coating;Polyamino acids for laboratory and research use relating to encapsulation, gene therapy, drug delivery, cell adhesion, and surface coating;POLYMERS;
ALAMANDA POLYMERS Alamanda Polymers, Inc. Suite A 1031 Putnam Drive Huntsville AL 35816 Polyamino acid synthesis services, namely, providing customized polyamino acids for laboratory and research use relating to encapsulation, gene therapy, drug delivery, cell adhesion, and surface coating; Providing consulting services and advice regarding polyamino acid synthesis for laboratory and research use relating to encapsulation, gene therapy, drug delivery, cell adhesion, and surface coating;Polyamino acids for laboratory and research use relating to encapsulation, gene therapy, drug delivery, cell adhesion, and surface coating;POLYMERS;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. A suspension of vector particles (PV) based on polyamino acids and have a mean hydrodynamic diameter between 30 and 120 nm, and an insulin load factor of from 5 to 25% of associated insulin volume relative to the polyamino acid volume forming the vector particles. The polyamino acids are double-block polymers containing hydrophilic and hydrophobic monomers. The suspension may be prepared by copolymerizing N-carboxy anhydrides of hydrophobic monomers and precursors of hydrophilic monomers, in the presence of N-methyl pyrrolidone and methanol. The copolymer is optionally neutralized, subjected to dialysis, concentrated and water is eliminated to produce a solid powder, which can be suspended in a liquid to produce the colloidal suspension. Active principles such as insulin or vaccines are associated with the carrier particles to prepare special pharmaceutical products.